ID

22044

Description

Study of Safety and Tolerability of Intravenous CRS-100 in Adults With Carcinoma and Liver Metastases; ODM derived from: https://clinicaltrials.gov/show/NCT00327652

Link

https://clinicaltrials.gov/show/NCT00327652

Keywords

  1. 5/16/17 5/16/17 -
  2. 5/16/17 5/16/17 -
  3. 9/20/21 9/20/21 -
Uploaded on

May 16, 2017

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Neoplasm Metastasis NCT00327652

Eligibility Neoplasm Metastasis NCT00327652

Criteria
Description

Criteria

1. documented carcinoma refractory to standard treatment (or for whom no standard treatment is available). hepatocellular carcinoma (hcc) is not allowed.
Description

Carcinoma | Standard therapy refractory | Standard therapy Unavailable | Liver carcinoma

Data type

boolean

Alias
UMLS CUI [1]
C0007097
UMLS CUI [2,1]
C2936643
UMLS CUI [2,2]
C0205269
UMLS CUI [3,1]
C2936643
UMLS CUI [3,2]
C0686905
UMLS CUI [4]
C2239176
2. hepatic metastases
Description

Secondary malignant neoplasm of liver

Data type

boolean

Alias
UMLS CUI [1]
C0494165
3. ecog performance status of 0 or 1, or karnofsky performance status (kps) of 80% to 100%.
Description

ECOG performance status | Karnofsky Performance Status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
UMLS CUI [2]
C0206065
4. adequate organ function as defined by clinical hematology and chemistry assays.
Description

Organ function

Data type

boolean

Alias
UMLS CUI [1]
C0678852
exclusion criteria (abbreviated):
Description

Exclusion Criteria

Data type

boolean

Alias
UMLS CUI [1]
C0680251
1. known central nervous system metastases.
Description

CNS metastases

Data type

boolean

Alias
UMLS CUI [1]
C0686377
2. history of allergic reactions attributed to sulfa or beta-lactam antibiotics.
Description

Allergy to sulfonamides | BETA LACTAM ALLERGY

Data type

boolean

Alias
UMLS CUI [1]
C0038757
UMLS CUI [2]
C0741476
3. cardiac conditions associated with high- or moderate-risk of endocarditis.
Description

Condition cardiac | Endocarditis High risk | Endocarditis Risk Moderate

Data type

boolean

Alias
UMLS CUI [1,1]
C0348080
UMLS CUI [1,2]
C0018787
UMLS CUI [2,1]
C0014118
UMLS CUI [2,2]
C0332167
UMLS CUI [3,1]
C0014118
UMLS CUI [3,2]
C0035647
UMLS CUI [3,3]
C0205081
4. intra-arterial hepatic catheter, hepatic cirrhosis, or clinically relevant ascites.
Description

Hepatic artery catheter | Liver Cirrhosis | Ascites

Data type

boolean

Alias
UMLS CUI [1]
C1321092
UMLS CUI [2]
C0023890
UMLS CUI [3]
C0003962
5. artificial (prosthetic) joint or other artificial implant or devices that cannot easily be removed.
Description

Artificial joint | Joint Prosthesis | Artificial Implants | Artificial structure

Data type

boolean

Alias
UMLS CUI [1]
C0481488
UMLS CUI [2]
C0022414
UMLS CUI [3]
C0021113
UMLS CUI [4]
C0336559
6. known coagulation disorder or recent thromboembolic event.
Description

Blood Coagulation Disorders | Thromboembolism

Data type

boolean

Alias
UMLS CUI [1]
C0005779
UMLS CUI [2]
C0040038
7. use of immunosuppressive agent, chemotherapy, or radiation therapy within 28 days prior to crs-100; bone marrow or stem cell transplant or a major organ allograft; autoimmune disease.
Description

Immunosuppressive Agents | Chemotherapy | Therapeutic radiology procedure | CRS-100 | Bone Marrow Transplantation | Stem cell transplant | Organ Major Allograft | Autoimmune Disease

Data type

boolean

Alias
UMLS CUI [1]
C0021081
UMLS CUI [2]
C0392920
UMLS CUI [3]
C1522449
UMLS CUI [4]
C1831855
UMLS CUI [5]
C0005961
UMLS CUI [6]
C1504389
UMLS CUI [7,1]
C0178784
UMLS CUI [7,2]
C0205164
UMLS CUI [7,3]
C0040739
UMLS CUI [8]
C0004364
8. current history of gallstones or kidney stones.
Description

Cholelithiasis | Nephrolithiasis

Data type

boolean

Alias
UMLS CUI [1]
C0008350
UMLS CUI [2]
C0392525
9. infection with hiv, human t-lymphotropic virus type 1 (htlv-1), hepatitis c virus (hcv), or hepatitis b virus (hbv).
Description

HIV Infection | Human T-cell lymphotropic virus 1 infection | Hepatitis C | Hepatitis B

Data type

boolean

Alias
UMLS CUI [1]
C0019693
UMLS CUI [2]
C1512326
UMLS CUI [3]
C0019196
UMLS CUI [4]
C0019163
10. pregnant or lactating
Description

Pregnancy | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147

Similar models

Eligibility Neoplasm Metastasis NCT00327652

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Carcinoma | Standard therapy refractory | Standard therapy Unavailable | Liver carcinoma
Item
1. documented carcinoma refractory to standard treatment (or for whom no standard treatment is available). hepatocellular carcinoma (hcc) is not allowed.
boolean
C0007097 (UMLS CUI [1])
C2936643 (UMLS CUI [2,1])
C0205269 (UMLS CUI [2,2])
C2936643 (UMLS CUI [3,1])
C0686905 (UMLS CUI [3,2])
C2239176 (UMLS CUI [4])
Secondary malignant neoplasm of liver
Item
2. hepatic metastases
boolean
C0494165 (UMLS CUI [1])
ECOG performance status | Karnofsky Performance Status
Item
3. ecog performance status of 0 or 1, or karnofsky performance status (kps) of 80% to 100%.
boolean
C1520224 (UMLS CUI [1])
C0206065 (UMLS CUI [2])
Organ function
Item
4. adequate organ function as defined by clinical hematology and chemistry assays.
boolean
C0678852 (UMLS CUI [1])
Exclusion Criteria
Item
exclusion criteria (abbreviated):
boolean
C0680251 (UMLS CUI [1])
CNS metastases
Item
1. known central nervous system metastases.
boolean
C0686377 (UMLS CUI [1])
Allergy to sulfonamides | BETA LACTAM ALLERGY
Item
2. history of allergic reactions attributed to sulfa or beta-lactam antibiotics.
boolean
C0038757 (UMLS CUI [1])
C0741476 (UMLS CUI [2])
Condition cardiac | Endocarditis High risk | Endocarditis Risk Moderate
Item
3. cardiac conditions associated with high- or moderate-risk of endocarditis.
boolean
C0348080 (UMLS CUI [1,1])
C0018787 (UMLS CUI [1,2])
C0014118 (UMLS CUI [2,1])
C0332167 (UMLS CUI [2,2])
C0014118 (UMLS CUI [3,1])
C0035647 (UMLS CUI [3,2])
C0205081 (UMLS CUI [3,3])
Hepatic artery catheter | Liver Cirrhosis | Ascites
Item
4. intra-arterial hepatic catheter, hepatic cirrhosis, or clinically relevant ascites.
boolean
C1321092 (UMLS CUI [1])
C0023890 (UMLS CUI [2])
C0003962 (UMLS CUI [3])
Artificial joint | Joint Prosthesis | Artificial Implants | Artificial structure
Item
5. artificial (prosthetic) joint or other artificial implant or devices that cannot easily be removed.
boolean
C0481488 (UMLS CUI [1])
C0022414 (UMLS CUI [2])
C0021113 (UMLS CUI [3])
C0336559 (UMLS CUI [4])
Blood Coagulation Disorders | Thromboembolism
Item
6. known coagulation disorder or recent thromboembolic event.
boolean
C0005779 (UMLS CUI [1])
C0040038 (UMLS CUI [2])
Immunosuppressive Agents | Chemotherapy | Therapeutic radiology procedure | CRS-100 | Bone Marrow Transplantation | Stem cell transplant | Organ Major Allograft | Autoimmune Disease
Item
7. use of immunosuppressive agent, chemotherapy, or radiation therapy within 28 days prior to crs-100; bone marrow or stem cell transplant or a major organ allograft; autoimmune disease.
boolean
C0021081 (UMLS CUI [1])
C0392920 (UMLS CUI [2])
C1522449 (UMLS CUI [3])
C1831855 (UMLS CUI [4])
C0005961 (UMLS CUI [5])
C1504389 (UMLS CUI [6])
C0178784 (UMLS CUI [7,1])
C0205164 (UMLS CUI [7,2])
C0040739 (UMLS CUI [7,3])
C0004364 (UMLS CUI [8])
Cholelithiasis | Nephrolithiasis
Item
8. current history of gallstones or kidney stones.
boolean
C0008350 (UMLS CUI [1])
C0392525 (UMLS CUI [2])
HIV Infection | Human T-cell lymphotropic virus 1 infection | Hepatitis C | Hepatitis B
Item
9. infection with hiv, human t-lymphotropic virus type 1 (htlv-1), hepatitis c virus (hcv), or hepatitis b virus (hbv).
boolean
C0019693 (UMLS CUI [1])
C1512326 (UMLS CUI [2])
C0019196 (UMLS CUI [3])
C0019163 (UMLS CUI [4])
Pregnancy | Breast Feeding
Item
10. pregnant or lactating
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial